Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
Condition(s):Covid19; Long COVID-19; Post-COVID-19 SyndromeLast Updated:January 25, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Covid19; Long COVID-19; Post-COVID-19 SyndromeLast Updated:January 25, 2023Completed
Condition(s):NADLast Updated:September 30, 2022Completed
Condition(s):HealthyLast Updated:January 27, 2023Recruiting
Condition(s):NAD+/NADH in Peripheral Blood MonitoringLast Updated:August 18, 2023Not yet recruiting
Condition(s):NADLast Updated:December 21, 2023Recruiting
Condition(s):Mild Cognitive Impairment; NADLast Updated:September 2, 2021Completed
Condition(s):Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)Last Updated:October 18, 2018Completed
Condition(s):AgingLast Updated:June 7, 2017Unknown status
Condition(s):Aging; Mitochondrial FunctionLast Updated:August 20, 2020Terminated
Condition(s):Skeletal MuscleLast Updated:February 6, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.